tirzepatide cardiovascular outcomes Long-awaited SURPASS-CVOT: with vs Dulaglutide in NEJM: #tirzepatide noninferior to #dulaglutide for 3-point MACE in T2D with ASCVD, with greater improvements in weight, A1c, BP, triglycerides, and kidney function Tirzepatide vs Dulaglutide for Cardiovascular

Weight-loss medications are available in pill form or as an injection

[DOI] [Google Scholar] 57.Serna-Escolano V., Gimnez M.J., Castillo S., Valverde J.M., Martnez-Romero D., Guilln F., Serrano M., Valero D., Zapata P.J

Patients taking prescription medicines, over-the-counter drugs, or herbal supplements should consult their healthcare providers to avoid adverse interactions

Whilst prescription GLP-1 medications are rigorously tested and regulated by the MHRA, probiotic supplements fall under food supplement regulations with less stringent evidence requirements

The risks are minimal and can include bruising at the injection site, or rarely, infection

The care to be provided in the skilled nursing facility needs to be medically necessary and reasonable